Neil Berkley, MS, MBA
Neil Berkley brings over 20 years of experience in corporate development, business development, and strategic planning from large pharma, midsize biotech/pharma and small biotech companies. He has completed a wide variety of transactions including in- and out-licensing transactions, M&A transactions, co-development/co-investment/co-commercialization transactions, research collaborations, financing transactions, device and supply agreements, etc. Neil has built and lead multiple business development, corporate development and alliance management teams.
Prior to joining Juvena, Neil was Chief Business Officer at AbCellera, a public biotech company focused on discovering novel antibody therapeutics. Previous to AbCellera, Neil was Vice President, Head of Business Development at Halozyme Therapeutics, a public biotechnology company focused on enabling platforms for the pharmaceutical industry. Neil has also held various business development and corporate development roles at Axerovision, COI (Avalon Incubator), Acadia, and GSK. Earlier in his career, Neil was Head of Business development at Cadence Pharmaceuticals, where he helped sell the company for $1.3B in cash. Neil also co-founded and helped build two San Diego-based biotechnology companies, Mpex Pharmaceuticals (acquired by Aptalis) and Vaxiion (a clinical stage bladder cancer company).
Neil holds a BS in molecular biology from the UC San Diego, as well as a Master of Science in cellular and molecular biology and an MBA from San Diego State University.
Learn more about Neil
LinkedIn
